Literature DB >> 19766988

Microwave-assisted efficient synthesis of glucose-based 3-acetyl-5-alkyl-2,3-dihydro-1,3,4-oxadiazole derivatives catalyzed by sodium acetate.

Lin-Na Wang1, Dong Han, Fei-Fei Xu, Xiang-Bao Meng, Zhong-Jun Li.   

Abstract

A novel approach to synthesize glucose-based 3-acetyl-5-alkyl-2,3-dihydro-1,3,4-oxadiazoles with the assistance of microwave irradiation was developed. The effects of different catalysts on the heterocyclization process were investigated, and the reaction conditions were optimized, with NaOAc emerging as the catalyst of choice. Under the optimized conditions, a series of novel 3-acetyl-5-alkyl-2,3-dihydro-1,3,4-oxadiazole derivatives 4 and 5 were successfully synthesized from hydrazones 2 and 3. The absolute configurations of hydrazones 2, 3 and oxadiazoles 4, 5 were confirmed by NMR spectroscopic data. The ratio of the isomers 4 and 5 was approximately 1:1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19766988     DOI: 10.1016/j.carres.2009.07.009

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  3 in total

1.  Quantitative and qualitative analysis of the novel antitumor 1,3,4-oxadiazole derivative (GLB) and its metabolites using HPLC-UV and UPLC-QTOF-MS.

Authors:  Pu Li; Xin Wang; Jian Li; Zhi-Yun Meng; Shu-Chun Li; Zhong-Jun Li; Ying-Yuan Lu; Hong Ren; Ya-Qing Lou; Chuang Lu; Gui-Fang Dou; Guo-Liang Zhang
Journal:  Sci Rep       Date:  2015-07-07       Impact factor: 4.379

2.  Novel 3-Acetyl-2,5-disubstituted-1,3,4-oxadiazolines: Synthesis and Biological Activity.

Authors:  Kinga Paruch; Łukasz Popiołek; Anna Biernasiuk; Anna Hordyjewska; Anna Malm; Monika Wujec
Journal:  Molecules       Date:  2020-12-10       Impact factor: 4.411

3.  Biological Activity, Lipophilicity and Cytotoxicity of Novel 3-Acetyl-2,5-disubstituted-1,3,4-oxadiazolines.

Authors:  Kinga Paruch; Anna Biernasiuk; Anna Berecka-Rycerz; Anna Hordyjewska; Łukasz Popiołek
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.